Prometheus to Use DNA Genotek Kits for Celiac Disease Risk Test | GenomeWeb

NEW YORK (GenomeWeb News) – DNA Genotek said today that Prometheus will use its sample-collection kits for a saliva-based genetic test for celiac disease.

Under the agreement, Prometheus will use DNA Genotek's Oragene DNA kit, a non-invasive DNA self-collection method, to collect saliva samples for the MyCeliacID test.

The DNA-based test is designed to detect variations in the DQ gene that are specific to celiac disease in order to estimate individual risk.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.